Tomás Dalotto‐Moreno

1.5k total citations
17 papers, 1.1k citations indexed

About

Tomás Dalotto‐Moreno is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Tomás Dalotto‐Moreno has authored 17 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 5 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Tomás Dalotto‐Moreno's work include Galectins and Cancer Biology (9 papers), Signaling Pathways in Disease (4 papers) and Immune Cell Function and Interaction (4 papers). Tomás Dalotto‐Moreno is often cited by papers focused on Galectins and Cancer Biology (9 papers), Signaling Pathways in Disease (4 papers) and Immune Cell Function and Interaction (4 papers). Tomás Dalotto‐Moreno collaborates with scholars based in Argentina, United States and Netherlands. Tomás Dalotto‐Moreno's co-authors include Gabriel A. Rabinovich, Mariana Salatino, Diego O. Croci, Santiago P. Méndez‐Huergo, Juan P. Cerliani, Marta A. Toscano, Sebastián Dergan‐Dylon, María Romina Girotti, Melissa R. Junttila and Iván Mascanfroni and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

Tomás Dalotto‐Moreno

17 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomás Dalotto‐Moreno Argentina 9 734 661 299 106 57 17 1.1k
Angelina I. Londoño-Joshi United States 10 150 0.2× 658 1.0× 267 0.9× 200 1.9× 70 1.2× 13 901
Sandra Cristea United States 8 344 0.5× 906 1.4× 898 3.0× 173 1.6× 22 0.4× 9 1.5k
Simona Blotta United States 12 189 0.3× 663 1.0× 452 1.5× 141 1.3× 42 0.7× 22 1.0k
Benoît Thibault France 12 160 0.2× 409 0.6× 312 1.0× 185 1.7× 100 1.8× 21 797
Abhijit Aithal United States 12 218 0.3× 428 0.6× 372 1.2× 163 1.5× 20 0.4× 23 809
Dawo Liu China 18 187 0.3× 456 0.7× 132 0.4× 174 1.6× 89 1.6× 30 665
Boris Kovačic Austria 17 389 0.5× 463 0.7× 692 2.3× 153 1.4× 11 0.2× 25 1.4k
Mark G. Cadungog United States 12 524 0.7× 540 0.8× 629 2.1× 148 1.4× 243 4.3× 17 1.3k
Debottam Sinha Australia 14 137 0.2× 426 0.6× 296 1.0× 120 1.1× 34 0.6× 28 783
Maree Bilandzic Australia 17 154 0.2× 391 0.6× 351 1.2× 157 1.5× 196 3.4× 29 884

Countries citing papers authored by Tomás Dalotto‐Moreno

Since Specialization
Citations

This map shows the geographic impact of Tomás Dalotto‐Moreno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomás Dalotto‐Moreno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomás Dalotto‐Moreno more than expected).

Fields of papers citing papers by Tomás Dalotto‐Moreno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomás Dalotto‐Moreno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomás Dalotto‐Moreno. The network helps show where Tomás Dalotto‐Moreno may publish in the future.

Co-authorship network of co-authors of Tomás Dalotto‐Moreno

This figure shows the co-authorship network connecting the top 25 collaborators of Tomás Dalotto‐Moreno. A scholar is included among the top collaborators of Tomás Dalotto‐Moreno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomás Dalotto‐Moreno. Tomás Dalotto‐Moreno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Salatino, Mariana, et al.. (2025). Abstract 6165: Antiprogestin- mediated endocrine therapy activates immunotherapy- responsive programs in hormone receptor positive breast tumors. Cancer Research. 85(8_Supplement_1). 6165–6165. 1 indexed citations
2.
Torres, Nicolás I., et al.. (2024). Do galectins serve as soluble ligands for immune checkpoint receptors?. Journal for ImmunoTherapy of Cancer. 12(4). e008984–e008984. 7 indexed citations
3.
Dalotto‐Moreno, Tomás, Helena Sterle, Santiago P. Méndez‐Huergo, et al.. (2023). Hypothyroidism‐associated immunosuppression involves induction of galectin‐1‐producing regulatory T cells. The FASEB Journal. 37(4). e22865–e22865. 8 indexed citations
4.
Dalotto‐Moreno, Tomás, Pablo Andrés García, Ada G. Blidner, et al.. (2021). Hypoxia Supports Differentiation of Terminally Exhausted CD8 T Cells. Frontiers in Immunology. 12. 660944–660944. 61 indexed citations
5.
Blidner, Ada G., et al.. (2021). [A functional platform to monitor SARS-CoV-2-specific T cell responses in vaccinated individuals and COVID-19 recovered patients].. PubMed. 81(5). 683–687. 1 indexed citations
6.
Luque, Guillermina M., Xinran Xu, Ana Romarowski, et al.. (2021). Cdc42 localized in the CatSper signaling complex regulates cAMP‐dependent pathways in mouse sperm. The FASEB Journal. 35(8). e21723–e21723. 17 indexed citations
7.
Dalotto‐Moreno, Tomás, Silvia I. Vanzulli, Derek C. Radisky, et al.. (2020). Enhanced Antitumor Immunity via Endocrine Therapy Prevents Mammary Tumor Relapse and Increases Immune Checkpoint Blockade Sensitivity. Cancer Research. 81(5). 1375–1387. 25 indexed citations
8.
Girotti, María Romina, Mariana Salatino, Tomás Dalotto‐Moreno, & Gabriel A. Rabinovich. (2019). Sweetening the hallmarks of cancer: Galectins as multifunctional mediators of tumor progression. The Journal of Experimental Medicine. 217(2). 131 indexed citations
9.
Martínez‐Bosch, Neus, Pedro Enrique Guerrero, Judith Vinaixa, et al.. (2018). Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor–stroma crosstalk. Proceedings of the National Academy of Sciences. 115(16). E3769–E3778. 125 indexed citations
10.
Luque, Guillermina M., Tomás Dalotto‐Moreno, David Martín‐Hidalgo, et al.. (2018). Only a subpopulation of mouse sperm displays a rapid increase in intracellular calcium during capacitation. Journal of Cellular Physiology. 233(12). 9685–9700. 35 indexed citations
11.
Dalotto‐Moreno, Tomás, et al.. (2018). [Immunotherapy in cancer. Current prospects, challenges and new horizons].. PubMed. 78(5). 336–348. 2 indexed citations
12.
Cerliani, Juan P., Tomás Dalotto‐Moreno, Daniel Compagno, et al.. (2014). Study of Galectins in Tumor Immunity: Strategies and Methods. Methods in molecular biology. 1207. 249–268. 6 indexed citations
13.
Croci, Diego O., Juan P. Cerliani, Tomás Dalotto‐Moreno, et al.. (2014). Glycosylation-Dependent Lectin-Receptor Interactions Preserve Angiogenesis in Anti-VEGF Refractory Tumors. Cell. 156(4). 744–758. 414 indexed citations
14.
Salatino, Mariana, Diego O. Croci, Diego J. Laderach, et al.. (2014). Regulation of Galectins by Hypoxia and Their Relevance in Angiogenesis: Strategies and Methods. Methods in molecular biology. 1207. 293–304. 3 indexed citations
15.
Salatino, Mariana, Tomás Dalotto‐Moreno, & Gabriel A. Rabinovich. (2013). Thwarting galectin-induced immunosuppression in breast cancer. OncoImmunology. 2(5). e24077–e24077. 5 indexed citations
16.
Spallanzani, Raúl G., Tomás Dalotto‐Moreno, Ximena L. Raffo Iraolagoitia, et al.. (2013). Expansion of CD11b+Ly6G+Ly6Cint cells driven by medroxyprogesterone acetate in mice bearing breast tumors restrains NK cell effector functions. Cancer Immunology Immunotherapy. 62(12). 1781–1795. 17 indexed citations
17.
Dalotto‐Moreno, Tomás, Diego O. Croci, Juan P. Cerliani, et al.. (2012). Targeting Galectin-1 Overcomes Breast Cancer-Associated Immunosuppression and Prevents Metastatic Disease. Cancer Research. 73(3). 1107–1117. 216 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Angelina I. Londoño-Joshi Breakdown of academic impact, for papers by Sandra Cristea Breakdown of academic impact, for papers by Simona Blotta Breakdown of academic impact, for papers by Benoît Thibault Breakdown of academic impact, for papers by Abhijit Aithal Breakdown of academic impact, for papers by Dawo Liu Breakdown of academic impact, for papers by Boris Kovačic Breakdown of academic impact, for papers by Mark G. Cadungog Breakdown of academic impact, for papers by Debottam Sinha Breakdown of academic impact, for papers by Maree Bilandzic
Rankless by CCL
2026